Bionobis signs a new agreement with one of the world leaders specializing in the manufacture of devices to fight against Covid-19.

Bionobis is positioned on the PRE-ANALYTICAL and ANALYTICAL market by presenting a complete range of MDs (for oropharyngeal / nasopharyngeal samples and saliva collection) as well as IVDDs to efficiently diagnose SARS-CoV-2.